Miscellaneous Receipts Act Exception for Veterans' Health Care Recoveries

Department of Justice Office of Legal Counsel·Decided December 3, 1998·Published

Opinion

Miscellaneous Receipts Act Exception for Veterans’ Health Care Recoveries T he Veterans R econciliation Act o f 1997 creates an exception to the M iscellaneous Receipts A ct to the extent that a recovery or collection under the Federal M edical Care Recovery Act is based on m edical care o r services furnished under chapter 17 o f title 38, United S tates Code, and thus allow s the d eposit o f such a recovery or collection in the D epartm ent of V eterans A ffairs M edical C are C ollections Fund.

December 3, 1998

M e m o r a n d u m O p in io n f o r t h e A s s is t a n t A t t o r n e y G e n e r a l C iv il D iv is io n

This responds to your request of May 28, 1998, that we examine whether certain funds received as part of a settlement under the Federal Medical Care Recovery Act, Pub. L. No. 87-693, 76 Stat. 593 (1962) ( “ MCRA” ), codified as amended at 42 U.S.C. §§2651-2653 (1994 & Supp. II 1996), may be transferred to the Department of Veterans Affairs Medical Care Collections Fund (“ VA Fund” ) notwithstanding the general requirement contained in the Miscellaneous Receipts Act (“ MRA” ) that “ an official or agent of the Government receiving money for the Government from any source shall deposit the money in the Treasury as soon as practicable without deduction for any charge or claim,” 31 U.S.C. § 3302(b) (1994). For the reasons outlined below, it is our view that the portion of the settlement amount that was calculated to compensate the Government for its claims under MCRA for medical care or services furnished under chapter 17 of Title 38, which governs certain veterans’ health benefits, may be transferred to the VA Fund by virtue of the Veterans Reconciliation Act of 1997, Pub. L. No. 105-33, § 8023(a)(1), 111 Stat. 251, 665, codified as amended at 38 U.S.C. § 1729A (Supp. IV 1998), which creates an exception to the MRA “ to the extent that a recovery or collection under . . . [MCRA] is based on medical care or services furnished under this chapter [i.e. Chapter 17 of Title 38].” 38 U.S.C. § 1729A(b)(6). Because the information that you have provided does not allow us to determine the amount of the settlement that was intended to compensate the federal government for its claims under MCRA, however, we are unable to give any more specific guidance on this issue.1

I. Settlement Background

In 1993, numerous tort actions brought in federal district courts throughout the country by persons with hemophilia against manufacturers of blood products were centralized as Multidistrict Litigation No. 986 before Judge Grady in the Northern

1We have no! been asked to address any other questions regarding this settlement

251 Opinions of the O ffice o f Legal Counsel in Volume 22

District o f Illinois. In these cases, individuals with hemophilia who contracted the HIV virus, and representatives of the estates of such individuals who have died, sued several companies who extracted the blood proteins that hemophiliacs lack (known as Factors VIE and IX ) from donated blood and provided these pro­ teins in the form o f “ factor concentrates” to hemophiliacs for injection. In addi­ tion to suing these “ Fractionaters,” as the companies are known based on the manufacturing process involved, plaintiffs also sued the National Hemophilia Foundation and individual health care providers.2 Although the United States chose not to intervene in the suits, it also had poten­ tial claims against the Fractionaters, including those under MCRA based on the provision of certain health care to veterans.3 MCRA provides a mechanism for the recoupment of certain medical costs and provides in relevant part:

In any case in which the United States is authorized or required by law to furnish or pay for hospital, medical, surgical, or dental care and treatment . . . to a person who is injured or suffers a disease . . . under circumstances creating a tort liability upon some third person . . . to pay damages therefor, the United States shall have a right to recover (independent o f the rights of the injured or diseased person) from said third person, or that person’s insurer, the reasonable value of the care and treatment so furnished, to be furnished, paid for, or to be paid for and shall, as to this right be subrogated to any right or claim that the injured or diseased person . . . [or] . . . estate . . . has against such third person to the extent of the reasonable value of the care and treatment so furnished, to be furnished, paid for, or to be paid for.

42 U.S.C. § 2 6 5 1(a). The Fractionaters commenced negotiations o f a global settlement of the claims o f the class m em bers4 and agreed to pay $100,000 for each approved claim, as well as a settlement with major private health care insurers, whom they agreed

2 See In re “Factor VIII o r IX Concentrate B lood Products," Product Liab. Litig., 853 F. Supp 454 (Judicial Panel on M ultidistnct Litigation 1993), Wadleigh v. Rhone-Poulenc Rorer, Inc., 157 F R .D 410 (N.D 111 1994), r e v ’d by order o f mandamus, In the M atter of Rhone-Poulenc Rorer I n c , 51 F 3d 1293 (7th C ir 1995), and cert, denied, 516 U.S. 867 (1995); In re Factor VIII o r IX Concentrate Blood Products Utig., 169 F.R.D 632 (N D 111 1996) 3 The draft memorandum from the Torts Branch to then-Acting Associate Attorney General John C Dwyer also discusses claim s (and potentially applicable recoupment provisions regarding claims) based on the provision of health care services to governm ent employees and their dependents under the Federal Employees Health Benefits Program as well as to individuals generally through the M edicare, Medicaid, and Indian Health Service programs. See Memo­ randum for John C. Dwyer, Acting Associate Attorney General, from Frank W Hunger, Assistant Attorney General, Civil Division, Re. Affirm ative Claims fo r Reimbursement o f Federally-Funded Health Care Provided to Persons with Hemophilia Infected with H IV (undated draft memorandum) 4 At the request o f the parties, Judge Grady approved a class specifically for settlement purposes after the Seventh Circuit had reversed Judge G rady’s p n o r certification o f a class for purposes of a trial. See In the Matter o f Rhone- Poulenc Rorer Inc., 51 F 3d at 1294-1304

252 Miscellaneous Receipts Act Exception fo r Veterans’ Health Care Recoveries

to pay ten cents per insured life in exchange for full release of all reimbursement and subrogation claims for recovery of costs of care or treatment o f class members arising from use of factor concentrates. The Fractionaters also approached the federal government with an offer to settle any claims of the United States based on the provision of health care to hemo­ philiacs, including veterans, who contracted the HIV virus. The Torts Branch, in cooperation with the respective agencies responsible for the health care services involved, entered into an out-of-court settlement with the Fractionaters, under which the latter paid the United States ten cents per federal health care system beneficiary and released the United States from all claims and actions arising out of, or related to, the use of factor concentrates by claimants.

Free access — add to your briefcase to read the full text and ask questions with AI

Miscellaneous Receipts Act Exception for Veterans' Health Care Recoveries, (olc 1998).

Miscellaneous Receipts Act Exception for Veterans' Health Care Recoveries (Miscellaneous Receipts Act Exception for Veterans' Health Care Recoveries) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In Re "Factor VIII or IX Concentrate Blood Products" Products Liability Litigation
853 F. Supp. 454 (Judicial Panel on Multidistrict Litigation, 1993)